IN8BIO INC (INAB)

US45674E1091 - Common Stock

1  -0.02 (-1.96%)

After market: 1.04 +0.04 (+4%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
30.34M28.52M14.65M8.56M5.06M
Research and Development
16.83M14.06M7.35M5.38M2.36M
Selling, General, and Administrative Expenses
13.51M14.46M7.31M3.18M2.71M
Operating Income
-30.34M-28.52M-14.65M-8.56M-5.06M
Interest Income/Expense
N/AN/AN/A0.000.00
Other Income/Expense
330.00KN/AN/A0.000.00
Non Recurring Items
N/AN/AN/A0.00-70.00K
Income Before Taxes
-30.01M-28.52M-14.65M-8.56M-5.13M
Income Tax
N/A0.000.000.000.00
Net Income
-30.01M-28.52M-14.65M-10.34M-5.91M
EBITDA
-28.50M-27.91M-14.02M-8.47M-4.96M
 
Per Share Data
EPS Diluted Total Ops
-1.00-1.36-0.78-0.55-0.30
Non GAAP EPS
-1.01-1.42N/AN/AN/A
 
Statistics

All data in USD

Charts